New drug may prevent dangerous blood pressure spikes in thyroid surgery
NCT ID NCT07434206
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether dexmedetomidine, a sedative, can safely control blood pressure and heart rate during surgery to remove active thyroid tumors. Eighty adults aged 20 to 65 are randomly assigned to receive either dexmedetomidine or the standard drug labetalol. The goal is to see if dexmedetomidine provides smoother blood pressure control without causing dangerous drops afterward.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexmedetomidine (Precedex)
What this could lead to
If it works, this could offer a safer way to manage blood pressure spikes during thyroid tumor surgery, reducing complications.
What could go wrong
This is a mid-stage trial with only 80 participants, so results may not apply to everyone. The drug may not outperform standard treatments and could cause low blood pressure or slow heart rate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
south Egypt cancer institute
Asyut, 171516, Egypt